Furiex Pharmaceuticals, Inc. - FORM 10-Q - EX-32.2 - SECTION 906 PFO CERTIFICATION - August 12, 2010

Attached files

file filename
10-Q - FORM 10-Q - Furiex Pharmaceuticals, Inc.d10q.htm
EX-32.1 - SECTION 906 PEO CERTIFICATION - Furiex Pharmaceuticals, Inc.dex321.htm
EX-31.1 - SECTION 302 PEO CERTIFICATION - Furiex Pharmaceuticals, Inc.dex311.htm
EX-31.2 - SECTION 302 PFO CERTIFICATION - Furiex Pharmaceuticals, Inc.dex312.htm

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Furiex Pharmaceuticals, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2010 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Marshall H. Woodworth, Vice President – Finance and Treasurer (principal financial and accounting officer) of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, to my knowledge that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

/s/ Marshall H. Woodworth

Marshall H. Woodworth

Vice President – Finance and Treasurer

(principal financial and accounting officer)

August 12, 2010

Furiex Pharmaceuticals, Inc. Reports